Duo Liu | Epidemiology | Best Researcher Award

Prof. Duo Liu | Epidemiology | Best Researcher Award 

Deputy Director, Department of Clinical Pharmacy | Harbin Medical University | China

Professor Duo Liu, Chief Pharmacist and Doctoral Supervisor at Harbin Medical University Cancer Hospital, is a distinguished pharmaceutical scientist whose research has significantly advanced the fields of pharmacogenomics, pharmacoepidemiology, and precision oncology. With a strong background in medical genetics and pharmacology, Professor Liu has developed a research portfolio that bridges molecular pharmacology with clinical translation, focusing on the genetic mechanisms underlying cancer susceptibility, therapeutic response, and drug resistance. His pioneering contributions include transcriptome-wide association studies identifying novel genetic determinants of pancreatic and prostate cancer risk, as well as investigations into the role of NADPH oxidase polymorphisms and oxidative stress in tumor biology and treatment outcomes. Professor Liu’s scholarly work, published in leading international journals such as Cancer Research, Carcinogenesis, and International Journal of Cancer, has garnered wide recognition for its methodological rigor and clinical relevance. He has successfully led multiple national and institutional research grants, including projects supported by the National Natural Science Foundation of China, and has been honored with several prestigious distinctions for excellence in pharmaceutical sciences and young investigator achievements. As an active member of numerous professional societies, including the Chinese Pharmacological Society and the Anti-Cancer Association of China, Professor Liu contributes to shaping the evolving landscape of cancer pharmacotherapy and drug epidemiology. His collaborations with global research institutions, notably the University of Hawaii Cancer Center, underscore his commitment to advancing international scientific exchange and translational medicine. Through his leadership in clinical pharmacy and mentorship of emerging scientists, Professor Liu continues to drive innovation in personalized cancer treatment and rational drug use, promoting evidence-based healthcare practices that enhance patient outcomes and public health impact worldwide.

Profile: ORCID 

Featured Publications

1. Chen, C., Dong, Q., Wang, H., Dong, S., Wang, S., Lin, W., Jia, C., Dong, M., Jin, Y., & Liu, D. (2025, January 8). The association between NADPH oxidase (NOX) polymorphisms with immunohistochemistry and survival in diffuse large B cell lymphoma patients. Annals of Hematology.

2. Wang, S. F., Dong, S. Q., Dong, Q., Lin, W. X., Dong, M., & Liu, D. (2024). Natural product-induced oxidative stress-synergistic anti-tumor effects of chemotherapeutic agents. Traditional Medicine Research.

3. Dong, S., Chen, C., Di, C., Wang, S., Dong, Q., Lin, W., & Liu, D. (2024, December). The association between NADPH oxidase 2 (NOX2) and drug resistance in cancer. Current Cancer Drug Targets.

4. Liu, D., Bae, Y. E., Zhu, J., Zhang, Z., Sun, Y., Deng, Y., Wu, C., & Wu, L. (2023, December 15). Splicing transcriptome-wide association study to identify splicing events for pancreatic cancer risk. Carcinogenesis.

5. Liu, D., Zhao, T., Zhu, J., Sharapov, S., Tiys, E., & Wu, L. (2023, December 4). Associations between genetically predicted plasma N-glycans and pancreatic cancer risk. All Life.

Mohammad Mehdi Akbarin | Virology | Best Researcher Award

Dr. Mohammad Mehdi Akbarin | Virology | Best Researcher Award 

Postdoctoral Fellow | UNAM | Mexico

Dr. Mohammad Mehdi Akbarin is a distinguished Iranian immunologist and molecular virologist whose academic and research pursuits bridge medical immunology, viral oncology, and immunogenetics. Currently serving as a Postdoctoral Fellow in Virology at the Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México (FESC–UNAM), his work focuses on understanding genetic variations that influence susceptibility and resistance to Bovine Leukemia Virus infection in cattle, contributing to translational advancements in comparative immunovirology. He earned his Ph.D. and M.Sc. in Medical Immunology from Mashhad University of Medical Sciences, where his pioneering research on HTLV-1 molecular pathogenesis, recombinant antigen development, and immunotherapeutic target design laid a foundation for novel diagnostic and therapeutic strategies against viral-associated malignancies such as Adult T-cell Leukemia/Lymphoma. Dr. Akbarin has authored and co-authored numerous peer-reviewed publications in high-impact international journals, covering areas such as cell signaling, host-virus interactions, and immune regulatory mechanisms, while also contributing to scientific books on human T-lymphotropic viruses and related diseases. His interdisciplinary collaborations span institutions across Iran, South Korea, and Mexico, underscoring his global engagement in biomedical research. Beyond his scholarly output, he has played instrumental roles in organizing international scientific congresses and mentoring medical and laboratory science students in immunology, bacteriology, and molecular diagnostics. His contributions to immunogenetics and translational virology have advanced the understanding of viral immune modulation and disease progression, reinforcing the link between molecular research and public health applications. Dr. Akbarin’s scientific vision centers on developing integrative molecular approaches for infectious disease control, cancer immunotherapy, and system biology-driven therapeutic innovation, embodying a commitment to advancing medical science and improving global health outcomes through precision immunology. He has 120 citations from 19 documents with an h-index of 7.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Tarokhian, H., Rahimi, H., Mosavat, A., Shirdel, A., Rafatpanah, H., Akbarin, M. M., et al. (2018). HTLV-1–host interactions on the development of adult T cell leukemia/lymphoma: Virus and host gene expressions.

2. Akbarin, M. M., Rahimi, H., HassanNia, T., Razavi, G. S., Sabet, F., & Shirdel, A. (2013). Comparison of HTLV-I proviral load in adult T cell leukemia/lymphoma (ATL), HTLV-I-associated myelopathy (HAM-TSP) and healthy carriers.

3. Ramezani, S., Shirdel, A., Rafatpanah, H., Akbarin, M. M., Tarokhian, H., et al. (2017). Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma. Medical Microbiology and Immunology

4. Akbarin, M. M., Shirdel, A., Bari, A., Mohaddes, S. T., Rafatpanah, H., Karimani, E. G., et al. (2017). Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients. Blood Research.

5. Jafarian, M., Mozhgani, S. H., Patrad, E., Vaziri, H., Rezaee, S. A., Akbarin, M. M., et al. (2017). Evaluation of INOS, ICAM-1, and VCAM-1 gene expression: A study of adult T cell leukemia malignancy associated.

Eze Ajaegbu | Infectious Diseases | Best Researcher Award

Dr. Eze Ajaegbu | Infectious Diseases | Best Researcher Award 

Senior Lecturer | David Umahi Federal University of Health Sciences | Nigeria

Dr. Eze Elijah Ajaegbue is a distinguished researcher currently serving as a Researcher on Vector Control and Cancer at David Umahi Federal University of Health Sciences, Nigeria. He earned his B.Sc. in Clinical Medicine from Anambra State University, Uli, and has further enhanced his expertise with a six-month Data Science course at PORA Academy, Nigeria, complementing his strong foundation in biomedical research. Dr. Ajaegbue’s research primarily focuses on vector-borne disease control, cancer biology, and diabetes-related studies, integrating epidemiology, nutrition, and translational health sciences. Over the years, he has contributed to numerous peer-reviewed publications exploring the mechanisms of disease transmission, preventive interventions, and innovative strategies to improve patient outcomes. His dedication to scientific excellence has earned him multiple awards and recognitions for research innovation and community impact, reflecting his commitment to both academic and public health advancement. Beyond his research, Dr. Ajaegbue plays an active role in editorial and peer-review capacities for several scientific journals, ensuring the dissemination of high-quality research in his field. His work is further distinguished by extensive community engagement, where he has led programs in schools, hospitals, and local organizations to promote academic development, nutrition awareness, and health education. With a unique blend of rigorous scientific inquiry, data-driven research approaches, and strong mentorship, Dr. Ajaegbue continues to make significant contributions to health research, vector control, and community well-being, positioning himself as a leading figure in advancing public health initiatives in Nigeria and beyond. He has 54 citations from 13 documents with an h-index of 4.

Profiles: Google Scholar | Scopus

Featured Publications

1. Ajaegbu, E. E., Danga, S. P. Y., Chijoke, I. U., & Okoye, F. B. C. (2016). Mosquito adulticidal activity of the leaf extracts of Spondias mombin L. against Aedes aegypti L. and isolation of active principles. Journal of Vector Borne Diseases.

2. Osonwa, U. E., Ugochukwu, J. I., Ajaegbu, E. E., Chukwu, K. I., Azevedo, R. B., et al. (2017). Enhancement of antibacterial activity of ciprofloxacin hydrochloride by complexation with sodium cholate. Bulletin of Faculty of Pharmacy, Cairo University.

3. Eze, E. A., Danga, S. P. Y., & Okoye, F. B. C. (2014). Larvicidal activity of the leaf extracts of Spondias mombin Linn. (Anacardiaceae) from various solvents against malarial, dengue and filarial vector mosquitoes (Diptera: Culicidae). Journal of Vector Borne Diseases.

4. Lame, Y., Nukenine, E. N., Pierre, D. Y. S., Elijah, A. E., & Esimone, C. O. (2015). Laboratory evaluations of the fractions efficacy of Annona senegalensis (Annonaceae) leaf extract on immature stage development of malarial and filarial mosquito vectors. Journal of Arthropod-Borne Diseases.

5. Victor, C., Moses, O., Eze, A., Festus, O., & Charles, E. (2018). Isolation, identification, and evaluation of biological activities of Daldinia eschscholtzii, an endophytic fungus isolated from the leaves of Musa paradisiaca. GSC Biological and Pharmaceutical Sciences.

Jack Ogony | Infectious Diseases | Outstanding Scientist Award

Dr. Jack Ogony | Infectious Diseases | Outstanding Scientist Award

Research Associate | Jaramogi Oginga Odinga University | Kenya

Dr. Jack Ogony is a distinguished Research Associate at the Institute for Health Research, Epidemiological Surveillance and Trainings (IRESSEF), with over 13 years of extensive experience in public health research across Sub-Saharan Africa. He is currently completing his PhD in Epidemiology and Biostatistics at Jomo Kenyatta University of Agriculture and Technology, having previously earned a Master’s in Epidemiology from the same institution, a Postgraduate Certificate in Monitoring and Evaluation from the Kenya Institute of Management, and a BSc in Medical Laboratory Science from Masinde Muliro University of Science and Technology. Dr. Ogony’s research primarily focuses on epidemiology, infectious diseases, climate change impacts on health systems, and vaccine and drug trial studies. He has contributed significantly to understanding the burden of Plasmodium falciparum and Dengue virus infections among under five in Western Kenya and the wider implications of climate change on African healthcare infrastructure. His work has been published in high-impact journals including Frontiers in Public Health, PLOS Global Public Health, and the East African Medical Journal, others, reflecting both the depth and breadth of his contributions. He has also served as Principal Investigator on multiple USAID-funded  under the Climate Adaptation Research Program (CARP). Recognized for his leadership and expertise, Dr. Ogony is a member of several professional organizations, including the American Society of Tropical Medicine and Hygiene and the African Society for Laboratory Medicine. He has earned awards for scientific excellence and serves as a peer reviewer for multiple journals, contributing to the advancement of global health research and capacity building in and infectious disease control across Africa. He has 28 citations from 5 documents with an h-index of 2.

Profile: Scopus | ORCID

Publications

1. Ogony, J., Menya, D., Mangeni, J. N., Ayodo, G., & Karanja, S. M. (2025). Public health facility vulnerabilities, preparedness and health outcomes for P. falciparum and Dengue virus infected children under 5 years with acute febrile illnesses in Western Kenya. Frontiers in Public Health, 13, 1526558.

2. Ogony, J., Mangeni, J., Ayodo, G., Amulen, E., Scopas, F., Juma, T., … & Hannah, C. (2025). The stifling burden of climate change on African public healthcare systems. Frontiers in Public Health, 13, 1559737.

3. Ogony, J., Karanja, S., Menya, D., Mangeni, J., & Ayodo, G. (2024). Prevalence and risk factors of Plasmodium falciparum and Dengue virus infections among children below 5 years with acute febrile illnesses in Kisumu and Busia Counties. East African Medical Journal, 101(12).

4. Owusu Agyare, B., Eder, P., Shenai, S., Chendi, B. H., Carlson, C., Iradukunda, A., Mukoka, M., Ogony, J., Manigart, O., O., O., Ogbaini-Emovon, E., & Seida, A. A. (2024). Potential implications of the climate crisis on diagnostics. PLOS Global Public Health, 4(3), e0002935.

5. Ogony, J., Obiero, B., Tukhuwa, B., Gondwe, C., Kampeta, E., Orner, C., & Tiruneh, T. (2021). Research knowledge translation activities in Africa: An outlook of the opportunities and obstacles. International Journal of Scientific Advances, 2(5), 8.

Hamidreza Aghababaeian | Public Health | Best Researcher Award

Dr. Hamidreza Aghababaeian | Public Health | Best Researcher Award

Faculty member at DUMS, Iran

Dr. Hamidreza Aghababaeian is a distinguished health scientist with in healthcare, academia, and disaster-related research. Holding a PhD in Health in Emergencies and Disasters, he has made significant contributions as Dean of the Center for Climate Change and Health Research and through leadership in numerous national projects on climate resilience, disaster preparedness, and environmental health impacts. His extensive publications, systematic reviews, and policy-oriented studies address urgent public health issues such as dust storms, extreme weather, and drought adaptation. As a faculty member, he has trained future professionals in disaster health, research methods, and emergency management, while also serving as an editorial board member and reviewer for leading international journals. His work demonstrates a strong blend of scholarly excellence, societal relevance, and leadership. With potential to expand global collaborations and adopt advanced analytical tools, he is highly deserving of the Best Researcher Award.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Dr. Hamidreza Aghababaeian possesses a strong academic foundation in health sciences, beginning with a Bachelor of Science in Nursing from Semnan University of Medical Sciences, Iran, followed by a Master of Science in Medical Surgical Nursing from Ahvaz University of Medical Sciences. He advanced his expertise with a PhD in Health in Emergencies and Disasters from Tehran University of Medical Sciences, focusing on the development of models to assess the health impacts of extreme weather events and dust storms. His academic journey reflects a commitment to integrating clinical knowledge with public health and disaster management, bridging the gap between patient care and large-scale emergency preparedness. Additionally, he has enriched his qualifications through specialized international training, including the Health Emergencies in Large Populations (HELP) course by the International Committee of the Red Cross, Health in Emergencies and Disasters courses, and the European Climate Resilient Health Systems Course, demonstrating dedication to lifelong learning and global expertise.

Experience

Dr. Hamidreza Aghababaeian has extensive professional experience spanning healthcare services, academic leadership, and disaster health research. He has served in health centers and disaster response fields, applying both clinical and strategic expertise. He has been a faculty member at Dezful University of Medical Sciences, teaching courses in health in emergencies and disasters, disaster management, triage, and research methodology. He has held leadership positions as a group manager and as the Dean of the Center for Climate Change and Health Research, where he directed numerous national projects on disaster resilience, climate change impacts, and environmental health risks. His professional contributions extend to scientific publishing as an editorial board member and peer reviewer for prestigious journals. Through a combination of teaching, research, and leadership, Dr. Aghababaeian has significantly advanced the field of disaster health and climate-related public health strategies.

Research Interest

Dr. Hamidreza Aghababaeian’s research interests lie at the intersection of public health, disaster medicine, and climate change, with a strong focus on understanding and mitigating the health impacts of environmental hazards. His work extensively explores extreme weather events, dust storms, heat and cold waves, drought, and their implications for morbidity, mortality, and health system resilience. He is particularly interested in developing models, frameworks, and policy strategies to strengthen healthcare preparedness and community resilience against climate change–induced risks. His research also examines the role of social resilience, sex-based health differences, and adaptation strategies in vulnerable populations, including those with disabilities. Through systematic reviews, meta-analyses, and applied field studies, he aims to translate scientific findings into actionable solutions for policymakers, healthcare providers, and disaster management authorities. Ultimately, his research seeks to bridge the gap between climate science, health systems, and community preparedness to enhance public health resilience at local, national, and global levels.

Award and Honor

Dr. Hamidreza Aghababaeian has earned recognition for his outstanding contributions to health sciences, disaster medicine, and climate change–related public health research. His leadership at the Center for Climate Change and Health Research and his pivotal role in numerous nationally significant projects have positioned him as a leading figure in advancing evidence-based strategies for disaster resilience and health system preparedness. He has been honored through appointments as an editorial board member for the Journal of Advanced Immunopharmacology and as a peer reviewer for prestigious international journals, including Frontiers in Public Health, PLOS One, and the Journal of Disaster Medicine and Public Health Preparedness. These roles reflect the scientific community’s trust in his expertise and scholarly judgment. His achievements also include invitations to participate in specialized international courses and collaborations, underscoring his global reputation. Collectively, these honors highlight his exceptional dedication, professional excellence, and lasting impact on public health and disaster management.

Research Skill

Dr. Hamidreza Aghababaeian possesses advanced research skills encompassing study design, data collection, statistical analysis, and scientific writing, with a particular expertise in public health, disaster medicine, and climate change–related health impacts. He is proficient in conducting systematic reviews, meta-analyses, and policy-oriented research, translating complex scientific evidence into practical strategies for health system resilience. His analytical capabilities are supported by strong command of statistical software such as SPSS and Excel, enabling him to perform detailed epidemiological and environmental health analyses. He has successfully managed multidisciplinary research projects, from conceptualization to dissemination, often involving collaboration with national and international stakeholders. His skill set extends to developing models and preparedness frameworks, designing adaptation strategies for vulnerable populations, and integrating qualitative and quantitative research methods. With extensive experience in peer review and editorial responsibilities, Dr. Aghababaeian demonstrates exceptional ability to critically evaluate scientific work while maintaining high standards of academic rigor and research integrity.

Publications Top Notes

Title: The concept of successful aging: a review article
Authors: F. Estebsari, M. Dastoorpoor, Z.R. Khalifehkandi, A. Nouri, D. Mostafaei
Year: 2020

Title: Air pollution and hospital admissions for cardiovascular diseases in Ahvaz, Iran
Authors: M. Dastoorpoor, Z. Sekhavatpour, K. Masoumi, M.J. Mohammadi
Year: 2019

Title: Global health impacts of dust storms: a systematic review
Authors: H. Aghababaeian, A. Ostadtaghizadeh, A. Ardalan, A. Asgary, M. Akbary
Year: 2021

Title: Alcohol intake in an attempt to fight COVID-19: A medical myth in Iran
Authors: H. Aghababaeian, L. Hamdanieh, A. Ostadtaghizadeh
Year: 2020

Title: The methanol poisoning outbreaks in Iran 2018
Authors: H. Aghababaeian, L. Araghi Ahvazi, A. Ostadtaghizadeh
Year: 2019

Title: Design and implementation of an empowerment model to prevent elder abuse: a randomized controlled trial
Authors: F. Estebsari, M. Dastoorpoor, D. Mostafaei, N. Khanjani, Z.R. Khalifehkandi
Year: 2018

Title: Heat waves and adaptation: A global systematic review
Authors: M. Kiarsi, M. Amiresmaili, M.R. Mahmoodi, H. Farahmandnia, N. Nakhaee
Year: 2023

Title: Lag time structure of cardiovascular deaths attributed to ambient air pollutants in Ahvaz, Iran, 2008–2015
Authors: M. Dastoorpoor, G. Goudarzi, N. Khanjan, E. Idani, H. Aghababaeian
Year: 2018

Conclusion

Based on his extensive academic qualifications, leadership in climate change and health research, prolific contributions to disaster and emergency health literature, and active engagement in scientific peer review, Dr. Hamidreza Aghababaeian is a highly deserving candidate for the Best Researcher Award. His career reflects a strong combination of scholarly excellence, societal impact, and mentorship. With continued focus on expanding international research collaborations and leveraging emerging technologies, he holds great potential to further influence global health resilience strategies and shape the next generation of health scientists.